Rocket Pharmaceuticals Inc Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Transcript - Thomson StreetEvents

Rocket Pharmaceuticals Inc Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Transcript

Rocket Pharmaceuticals Inc Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Transcript - Thomson StreetEvents
Rocket Pharmaceuticals Inc Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Transcript
Published May 15, 2025
22 pages (12260 words) — Published May 15, 2025
Price US$ 106.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of RCKT.OQ conference call or presentation 15-May-25 8:30pm GMT

  
Brief Excerpt:

...Operator Thank you for standing by, and welcome to the Rocket Pharma investor conference call. (Operator Instructions) I'd now like to hand the conference over to your host, Meg Dodge, Head of Investor Relations and Corporate Communications. Please begin. Meg Dodge ...

  
Report Type:

Transcript

Source:
Company:
Rocket Pharmaceuticals Inc
Ticker
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Rocket Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript – 2025-01-13 – US$ 54.00 – Edited Transcript of RCKT.OQ presentation 13-Jan-25 11:45pm GMT

Rocket Pharmaceuticals Inc Investor Webinar Transcript – 2024-11-18 – US$ 54.00 – Edited Transcript of RCKT.OQ corporate analyst meeting</ 18-Nov-24 5:00pm GMT

Rocket Pharmaceuticals Inc at UBS Global Healthcare Conference Transcript – 2024-11-13 – US$ 54.00 – Edited Transcript of RCKT.OQ presentation 13-Nov-24 1:00am GMT

Rocket Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript – 2024-09-05 – US$ 54.00 – Edited Transcript of RCKT.OQ presentation 5-Sep-24 6:35pm GMT

Rocket Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript – 2024-05-16 – US$ 54.00 – Edited Transcript of RCKT.OQ presentation 16-May-24 5:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Rocket Pharmaceuticals Inc Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Transcript" May 15, 2025. Alacra Store. May 17, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Rocket-Pharmaceuticals-Inc-Presents-Preliminary-Data-from-Phase-1-Clinical-Trial-of-RP-A601-for-PKP2-Arrhythmogenic-Cardiomyopathy-T16379415>
  
APA:
Thomson StreetEvents. (2025). Rocket Pharmaceuticals Inc Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Transcript May 15, 2025. New York, NY: Alacra Store. Retrieved May 17, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Rocket-Pharmaceuticals-Inc-Presents-Preliminary-Data-from-Phase-1-Clinical-Trial-of-RP-A601-for-PKP2-Arrhythmogenic-Cardiomyopathy-T16379415>
  
US$ 106.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.